Literature DB >> 22835548

Indole-3-carbinol disrupts estrogen receptor-alpha dependent expression of insulin-like growth factor-1 receptor and insulin receptor substrate-1 and proliferation of human breast cancer cells.

Crystal N Marconett1, Ankur K Singhal, Shyam N Sundar, Gary L Firestone.   

Abstract

We previously established that Indole-3-Carbinol (I3C), a natural hydrolysis product of glucobrassicin in cruciferous vegetables, arrests the proliferation of estrogen-dependent human breast cancer cells and induces protein degradation of Estrogen Receptor-alpha (ERα). We demonstrate in human MCF-7 breast cancer cells that I3C ablates expression of Insulin-like Growth Factor Receptor-1 (IGF1R) and Insulin Receptor Substrate-1 (IRS1), downstream effectors of the IGF1 signaling pathway. Exogenous ERα reversed the I3C mediated loss of IGF1R and IRS1 gene expression demonstrating that down-regulation of ERα is functionally linked to I3C control of IGF1R and IRS1 expression. I3C disrupted binding of endogenous ERα, but not Sp1, to ERE-Sp1 composite elements within the IGF1R/IRS1 promoters. Exogenous ERα abrogated, and combined expression of IGF1R and IRS1 attenuated, the I3C mediated cell cycle arrest. Therefore, I3C inhibits proliferation of estrogen-sensitive breast cancer cells through disruption of ERα-mediated transcription of cell signaling components within the IGF1 cascade.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22835548      PMCID: PMC3684449          DOI: 10.1016/j.mce.2012.07.008

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  53 in total

1.  Estradiol increases IRS-1 gene expression and insulin signaling in breast cancer cells.

Authors:  L Mauro; M Salerno; M L Panno; D Bellizzi; D Sisci; A Miglietta; E Surmacz; S Andò
Journal:  Biochem Biophys Res Commun       Date:  2001-11-02       Impact factor: 3.575

Review 2.  Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.

Authors:  E Surmacz; M Bartucci
Journal:  J Exp Clin Cancer Res       Date:  2004-09

Review 3.  Molecular targets and anticancer potential of indole-3-carbinol and its derivatives.

Authors:  Bharat B Aggarwal; Haruyo Ichikawa
Journal:  Cell Cycle       Date:  2005-09-06       Impact factor: 4.534

4.  Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells.

Authors:  C M Cover; S J Hsieh; E J Cram; C Hong; J E Riby; L F Bjeldanes; G L Firestone
Journal:  Cancer Res       Date:  1999-03-15       Impact factor: 12.701

5.  Polyethylene glycol conjugated insulin-like growth factor binding protein-1 (IGFBP-1) inhibits growth of breast cancer in athymic mice.

Authors:  C L Van den Berg; G N Cox; C A Stroh; S G Hilsenbeck; C N Weng; M J McDermott; D Pratt; C K Osborne; E B Coronado-Heinsohn; D Yee
Journal:  Eur J Cancer       Date:  1997-06       Impact factor: 9.162

Review 6.  ERα-associated protein networks.

Authors:  Jennifer R Schultz-Norton; Yvonne S Ziegler; Ann M Nardulli
Journal:  Trends Endocrinol Metab       Date:  2011-03-02       Impact factor: 12.015

7.  Involvement of insulin receptor substrate 2 in mammary tumor metastasis.

Authors:  Julie A Nagle; Zhefu Ma; Maura A Byrne; Morris F White; Leslie M Shaw
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

8.  Estrogen receptor alpha as a target for indole-3-carbinol.

Authors:  Thomas T Y Wang; Matthew J Milner; John A Milner; Young S Kim
Journal:  J Nutr Biochem       Date:  2005-11-28       Impact factor: 6.048

9.  Type 1 insulin-like growth factor receptor signaling is essential for the development of the hippocampal formation and dentate gyrus.

Authors:  Wen Liu; Ping Ye; John R O'Kusky; A Joseph D'Ercole
Journal:  J Neurosci Res       Date:  2009-10       Impact factor: 4.164

Review 10.  Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects.

Authors:  Richard Santen; Ercole Cavalieri; Eleanor Rogan; Jose Russo; Joseph Guttenplan; James Ingle; Wei Yue
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

View more
  15 in total

1.  Dietary Indoles Suppress Delayed-Type Hypersensitivity by Inducing a Switch from Proinflammatory Th17 Cells to Anti-Inflammatory Regulatory T Cells through Regulation of MicroRNA.

Authors:  Narendra P Singh; Udai P Singh; Michael Rouse; Jiajia Zhang; Saurabh Chatterjee; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Immunol       Date:  2015-12-28       Impact factor: 5.422

Review 2.  The links between insulin resistance, diabetes, and cancer.

Authors:  Etan Orgel; Steven D Mittelman
Journal:  Curr Diab Rep       Date:  2013-04       Impact factor: 4.810

Review 3.  Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Authors:  Mark A Feitelson; Alla Arzumanyan; Rob J Kulathinal; Stacy W Blain; Randall F Holcombe; Jamal Mahajna; Maria Marino; Maria L Martinez-Chantar; Roman Nawroth; Isidro Sanchez-Garcia; Dipali Sharma; Neeraj K Saxena; Neetu Singh; Panagiotis J Vlachostergios; Shanchun Guo; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Alan Bilsland; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; W Nicol Keith; Somaira Nowsheen
Journal:  Semin Cancer Biol       Date:  2015-04-17       Impact factor: 15.707

Review 4.  Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.

Authors:  Min Ji Bak; Soumyasri Das Gupta; Joseph Wahler; Nanjoo Suh
Journal:  Semin Cancer Biol       Date:  2016-03-22       Impact factor: 15.707

Review 5.  Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: promising options for prevention and treatment of uterine fibroids?

Authors:  Md Soriful Islam; Most Mauluda Akhtar; Andrea Ciavattini; Stefano Raffaele Giannubilo; Olga Protic; Milijana Janjusevic; Antonio Domenico Procopio; James H Segars; Mario Castellucci; Pasquapina Ciarmela
Journal:  Mol Nutr Food Res       Date:  2014-06-30       Impact factor: 5.914

Review 6.  Dietary Natural Products for Prevention and Treatment of Breast Cancer.

Authors:  Ya Li; Sha Li; Xiao Meng; Ren-You Gan; Jiao-Jiao Zhang; Hua-Bin Li
Journal:  Nutrients       Date:  2017-07-08       Impact factor: 5.717

7.  Pharmacophore modeling for identification of anti-IGF-1R drugs and in-vitro validation of fulvestrant as a potential inhibitor.

Authors:  Samra Khalid; Rumeza Hanif; Ishrat Jabeen; Qaisar Mansoor; Muhammad Ismail
Journal:  PLoS One       Date:  2018-05-22       Impact factor: 3.240

Review 8.  Natural products as potential cancer therapy enhancers: A preclinical update.

Authors:  Abed Agbarya; Nili Ruimi; Ron Epelbaum; Eran Ben-Arye; Jamal Mahajna
Journal:  SAGE Open Med       Date:  2014-09-02

9.  Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells.

Authors:  Antony S Tin; Anna H Park; Shyam N Sundar; Gary L Firestone
Journal:  BMC Biol       Date:  2014-09-12       Impact factor: 7.431

10.  Effects of indole-3-carbinol on steroid hormone profile and tumor progression in a mice model of canine inflammatory mammarycancer.

Authors:  Asunción Martín-Ruiz; Laura Peña; Alfredo González-Gil; Lucía Teresa Díez-Córdova; Sara Cáceres; Juan Carlos Illera
Journal:  BMC Cancer       Date:  2018-06-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.